Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
Overall survival vs immunohistochemistry. The Kaplan Meier graph... | Download Scientific Diagram
A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink
A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC
CLEAR Study: First-Line Lenvatinib Plus Pembrolizumab Maintains Advantage Over Sunitinib in Advanced RCC at Long-Term Follow-up
Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect
Current Oncology | Free Full-Text | Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine
Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy - Clinical Genitourinary Cancer
Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system - Figure f1 | Aging
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer
Oncotarget: Identification intermediate-risk | EurekAlert!
Kaplan–Meier curves showing recurrence-free survival and overall... | Download Scientific Diagram
Stream Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD by Oncology Data Advisor® | Listen online for free on SoundCloud
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis
BioCentury - The latest twist in the overall survival debate
Oncology Data Advisor - Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma
Prognostic Value of Serum CA9 in Patients with Metastatic Clear Cell Renal Cell Carcinoma under Targeted Therapy | Anticancer Research
